SoftOx Solutions AS

Research SoftOx Solutions AS (SOFTX) on Bullrun: market cap NOK 229.29M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerSOFTX
ExchangeOL
CountryNorway
SectorHealthcare
IndustryBiotechnology
CurrencyNOK
Market capNOK 229.29M
Financial periodFY2025
RevenueNOK 15.58M
Net income-NOK 10.81M
Free cash flow-NOK 18.87M

Valuation Snapshot

latest market cap is NOK 229.29M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	NOK 15.58M	-NOK 10.81M	-NOK 18.87M	n/a	0	NOK 19.79M	NOK 0	NOK 22.95M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	NOK 229.29M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 NOK.

About SoftOx Solutions AS

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.

Related stock research

Norway stocks Norway Healthcare stocks A-Z stock index

Other Healthcare stocks

Selvaag Bolig ASA (0Q92) Aqua Bio Technology ASA (ABTEC) Arcticzymes Technologies ASA (B4V) Circio Holding ASA (CRNA) Exact Therapeutics AS (EXTX) Lytix Biopharma AS (LYTIX) Nykode Therapeutics ASA (NYKD) Oncoinvent ASA (ONCIN) Thor Medical ASA (TRMED) Zelluna ASA (ZLNA) Medistim ASA (0OCD) NORDHEALTH AS NK 1 (6E5)

Frequently asked questions

What is SoftOx Solutions AS's market cap?

SoftOx Solutions AS's market capitalization is NOK 229.29M.